Remove 2010 Remove Kidney Disease Remove Outcomes
article thumbnail

Trends in prognosis and use of SGLT2i and GLP-1 RA in patients with diabetes and coronary artery disease

Cardiovascular Diabetology

Objective To explore trends in prognosis and use of glucose-lowering drugs (GLD) in patients with diabetes and coronary artery disease (CAD). Research design and methods All patients with diabetes and CAD undergoing a coronary angiography between 2010 and 2021 according to the Swedish Angiography and Angioplasty Registry were included.

article thumbnail

Dialysis Modality and Incident Stroke Among Patients With End-Stage Kidney Disease: A Registry-Based Cohort Study

Stroke Journal

BACKGROUND:Patients with end-stage kidney disease undergoing dialysis are at significant risk of stroke. Whether dialysis modality is associated with cerebrovascular disease is unclear. The primary outcome was incident acute ischemic stroke. Stroke, Volume 54, Issue 12 , Page 3054-3063, December 1, 2023.

article thumbnail

Remembering CMHC Chair Dr. George L. Bakris: An Exceptional Leader, Mentor, and Educator in Nephrology and Hypertension 

Cardiometabolic Health Congress

Bakris’s distinguished career in medicine spanned over four decades, marked by significant contributions to the fields of diabetic kidney disease, hypertension, and nephropathy progression. His work was particularly influential in understanding racial disparities in disease progression and developing targeted interventions.

article thumbnail

Changing trends in the incidence, management and outcomes of coronary artery perforation over an 11-year period: single-centre experience

Open Heart

This study aimed to assess the incidence, management and outcomes of CP over time. Methods A single-centre retrospective cohort study of all PCIs performed between January 2010 and December 2020. Introduction Coronary artery perforation (CP) is a rare but life-threatening complication of percutaneous coronary intervention (PCI).

article thumbnail

Atrial fibrillation outcomes in patients from Asia and non-Asia countries: insights from GARFIELD-AF

Open Heart

Background Differences in the clinical outcomes and level of risk among Asian versus non-Asian patients with atrial fibrillation (AF) have been sparsely investigated. Objective To provide a contemporary prospective comparison of outcomes for newly diagnosed patients with AF, between Asian and non-Asian regions. to 0.99), 0.52 (0.28